With Interchangeability Nod, Viatris' Semglee Loses Its Identity

 
• By Sue Sutter
  
The US FDA's first-ever interchangeable designation opens new roads for biosimilars. • Source: Nielsen Hobbs
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics